Women's Health Therapeutics Market to 2018 – Unmet Need for Safe and Effective Treatments due to Unfavorable Risk …

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p01041700/Women's-Health-Therapeutics-Market-to-2018---Unmet-Need-for-Safe-and-Effective-Treatments-due-to-Unfavorable-Risk/Benefit-Profile-Associated-with-Hormone-Replacement-Therapy.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Women's Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy

In 2011, the women's health therapeutics market was estimated to be worth $18.8 billion. GBI Research forecasts the market to grow at a Compound Annual Growth Rate (CAGR) of 2.7% between 2011 and 2018, to record a sales value of $22.7 billion in 2018. The patent expiries of blockbusters such as Evista, the Premarin family, Forteo, Mirena, Boniva, Actonel, Gonal-F and others during the forecast period are expected to slow down the market growth for the women's health therapeutics market. The launch of novel molecules like Elagolix and Odanacatib in the late stage pipeline will drive the market in the forecast period.

The women's health therapeutics market R&D pipeline shows promising molecules. The current treatment options for women's disorders are limited due to lack of safety. The unmet need in the women's disorders market is attracting the pharmaceutical companies to invest in R&D programs. Increased focus is seen on therapy areas such as menopause, female sexual dysfunction and infertility.

- Analysis of the leading therapeutic segments, including menopause, postmenopausal osteoporosis, endometriosis, infertility, and the female contraceptives market.

- Analysis of the women's health therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.

- Market characterization of the women's health therapeutics market, including market size, annual cost of therapy and treatment usage patterns.

- Key drivers and barriers that have a significant impact on the market.

- Coverage of pipeline molecules in various phases of drug development.

See more here:
Women's Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk ...